Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Tax Provisions (2019 - 2026)

Inspire Medical Systems' Tax Provisions history spans 8 years, with the latest figure at $13.7 million for Q1 2026.

  • On a quarterly basis, Tax Provisions rose 1073.18% to $13.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$67.2 million, a 1319.23% decrease, with the full-year FY2025 number at -$79.7 million, down 1712.56% from a year prior.
  • Tax Provisions hit $13.7 million in Q1 2026 for Inspire Medical Systems, up from -$85.7 million in the prior quarter.
  • Over the last five years, Tax Provisions for INSP hit a ceiling of $13.7 million in Q1 2026 and a floor of -$85.7 million in Q4 2025.
  • Historically, Tax Provisions has averaged -$3.5 million across 5 years, with a median of $477000.0 in 2023.
  • Biggest five-year swings in Tax Provisions: crashed 6171.18% in 2025 and later surged 1073.18% in 2026.
  • Tracing INSP's Tax Provisions over 5 years: stood at $125000.0 in 2022, then skyrocketed by 281.6% to $477000.0 in 2023, then soared by 196.02% to $1.4 million in 2024, then crashed by 6171.18% to -$85.7 million in 2025, then surged by 115.97% to $13.7 million in 2026.
  • Business Quant data shows Tax Provisions for INSP at $13.7 million in Q1 2026, -$85.7 million in Q4 2025, and $3.6 million in Q3 2025.